CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Cash Flow Statement
CELZ|14 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$6M
FY2025
Free Cash Flow
N/A
FY2025
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2025
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. used $6M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.0M | -$5.5M | -$10.1M | $19.2M | -$36.3M | -$8.5M | -$13.7M | -$2.7M | -$766.1K | -$766.1K | -$28.0K | -$27.3K | -$25.6K | -$17.3K |
| Depreciation & Amortization | - | $56.0K | $56.0K | - | - | - | - | - | - | - | - | - | - | - |
| Operating Cash Flow | -$5.9M | -$5.3M | -$7.8M | -$2.2M | -$434.6K | -$1.2M | -$1.1M | -$889.6K | -$445.2K | $445.2K | -$17.3K | -$22.9K | -$16.8K | -$13.7K |
| Share Buybacks | $10.0K | $175.0K | $0 | - | - | - | - | - | - | - | - | - | - | - |